Miconazole: Difference between revisions
Elcatracho (talk | contribs) |
(Replace manual dosing with dynamic SMW tables) |
||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
=== | ===Indications by Disease=== | ||
{{#ask: [[Has DrugName::Miconazole]] [[Has Population::Adult]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
=== | |limit=50 | ||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
=== | ===Indications by Disease=== | ||
{{#ask: [[Has DrugName::Miconazole]] [[Has Population::Pediatric]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
=== | |limit=50 | ||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Special Populations== | ==Special Populations== | ||
Revision as of 01:54, 20 March 2026
Administration
- Type: Antifungal
- Dosage Forms: 2% Cream
- Routes of Administration: Topical
- Common Trade Names: Monistat-Derm, Desenex, Lotrimin, Micatin, Zeasorb
Adult Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Candida vulvovaginitis | 2% cream applied vaginally for 7 days OR 4% cream x 3 days | Intravaginal therapy |
| Candidiasis | 2% cream applied topically BID x 2 weeks | Cutaneous candidiasis |
| Tinea corporis | 2% cream applied topically BID x 4 weeks | Mild disease |
| Tinea cruris | 2% cream applied topically BID x 2 weeks | Topical antifungal |
| Tinea pedis | 2% cream applied topically BID x 4 weeks | Topical antifungal |
Pediatric Dosing
Indications by Disease
Special Populations
Pregnancy Rating
- Risk of fetal harm no expected
- May use during pregnancy
Lactation risk
- May use while breastfeeding
Renal Dosing
- Adult: Not defined
- Pediatric: Not defined
Hepatic Dosing
- Adult: Not defined
- Pediatric: Not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- May occur, but none reported
Common
- Irritation, burning, stining
- Pruritus, erythema, maceration
- Contact dermatitis
Pharmacology
- Half-life: Unknown
- Metabolism: None, minimal systemic absorption
- Excretion: None
Mechanism of Action
- Inhibits 14-alpha demethylase, reducing fungal cell membrane ergosterol synthesis